Chemotherapy dose banding
National dose banding tables
The chemotherapy dose standardisation initiative has been developed by NHS England’s Medicine Optimisation and Chemotherapy Clinical Reference Groups. NHS England is supporting the standardisation of chemotherapy doses which will deliver benefits for patients, hospital trusts and achieve improved value from our investment in chemotherapy services.
Historically when patients received chemotherapy intravenously their dose would be based on a combination of their height and weight and would mean that pharmacies would waste any medicine left over from vials containing fixed doses. A number of hospitals have already moved to a system of dose banding where a range of doses are delivered to closely match to vial size. This means there is reduced waste and as these doses tend to be ready made it also reduces the waiting time for patients within the chemotherapy unit.
The national dose banding tables are to be used by hospital trust pharmacy teams to ensure a standard approach to dose banding of chemotherapy across all hospital trusts. The initiative is initially focussed on 19 commonly used drugs. This will help the NHS achieve improved value through the ability to purchase standard off the shelf products.
- National dose banding table – 2mgmL – v7
- National dose banding table – 25mgmL – v2
- National dose banding table – 80mgmL – v2
- National dose banding table – Avelumab 20mgmL – v2
- National dose banding table – Azacitidine 25mgmL – v3
- National dose banding table – Bendamustine 45mgmgmL v1
- National dose banding table – Bevacizumab 25mgmL – v2
- National dose banding table – Brentuximab Vedotin 5mgmL – v3
- National dose banding table – Capecitabine v1
- National dose banding table – Carfilzomib 2mgmL v7
- National dose banding table – Cladribine SC Litak 2mgml v1
- National dose banding table – Cetuximab 5mgmL – v4
- National dose banding table – Clofarabine 1mgmL – v2
- National dose banding table – Daratumumab 20mgmL v1
- National dose banding table – Doxorubicin Lip (Caelyx) 2mgmL – v3
- National dose banding table – Durvalumab 50mgml v1
- National dose banding table – Eribulin 0.44mgmL v3
- National dose banding table – Irinotecan 20mgml v.1
- National dose banding table – Inotuzumab ozogamicin 0.25mgml v1
- National dose banding table – Ipilimumab 5mgmL v1
- National dose banding table – Isatuximab 20mg/mL v1
- National dose banding table – Mesna 100mgmL – v5
- National dose banding table – Methotrexate HD 100mgmL – v2
- National Dose Banding Table – Mogamulizumab 4mgmL – v1
- National dose banding table – Nivolumab 10mgmL – v3
- National dose banding table – Paclitaxel Albumin 5mgmL – v1
- National dose banding table – Panitumumab 20mgmL – v1
- National dose banding table – Pembrolizumab 25mgmL – v3
- National dose banding table – Pemetrexed 25mgmL v3
- National dose banding table – Polatuzumab vedotin 20mg mL v1
- National dose banding table – Rituximab 10mgmL – v4
- National Dose Banding Table – Sacituzumab govitecan 10mg/mL
- National dose banding table – Topotecan 1mgmL – v3
- National dose banding table – Trastuzumab IV 21mgmL – v2
- National dose banding table – Trastuzumab emtansine 20mgmL – v2
- National dose banding table- Trastuzumab deruxtecan 20mg/mL v1
- National dose banding table – Temozolomide PO v2
- National dose banding table – Vinflunine 25mgmL – v2
- National dose banding table – Vyxeos liposomal 2.2mg5mgmL v1